Crowdsourcing a medical diagnosis for sexually transmitted diseases (STDs) throughout various health communities on the Internet has become a new trend, a JAMA study showed.1
Many Internet users are sharing images of STDs, such as genital sores or rashes, with the public, followed by a detailed description of their symptoms. Answers from other users are usually within minutes of the original post.1
The study found that 90% of posts received a reply in the course of 24 hours. In addition, 20% of the people asked the crowd for a second opinion after already being diagnosed by a medical professional for STDs.1
Experts say that the crowdsourcing trend might stem from a lack of money to pay for medical services or setting up a timely appointment with a doctor. However, this trend has stirred up mixed opinions with different doctors across the country.1
Dr. Amesh Adalja sees an opportunity in utilizing health care through social media. "This phenomenon should be seen as an opportunity for health care providers to engage with patients on social media to ensure accurate diagnosis and advice is being given," said Adalja, a senior scholar at the Johns Hopkins Center on Health Security in Baltimore who also reviewed the JAMA study. "Exploiting the ease of social media inquiry will likely become an increasingly important way to interact with patients."2
On the other hand, STD specialist Dr. Ina Park sees the downfall of crowdsourcing. “For those who already have a medical diagnosis and are still seeking a second opinion through crowdsourcing, I do think it’s potentially dangerous because you have no idea who’s giving you this advice and their expertise.”1
References
- Some crowdsource their STD diagnosis on the internet. Here’s why that’s dangerous to everyone. CNN Health. https://www.cnn.com/2019/11/05/health/stds-reddit-crowdsource-wellness/index.html. Published November 5, 2019. Accessed November 6, 2019.
- ‘Hey, What is This?’: Social media, not docs, increasingly diagnosing STDs. U.S. News. https://www.usnews.com/news/health-news/articles/2019-11-05/hey-what-is-this-social-media-not-docs-increasingly-diagnosing-stds. Published November 5, 2019. Accessed November 6, 2019.
Social Media Plays a Major Role in Diagnosing Sexually Transmitted Diseases
Crowdsourcing a medical diagnosis for sexually transmitted diseases (STDs) throughout various health communities on the Internet has become a new trend, a JAMA study showed.
Crowdsourcing a medical diagnosis for sexually transmitted diseases (STDs) throughout various health communities on the Internet has become a new trend, a JAMA study showed.1
Many Internet users are sharing images of STDs, such as genital sores or rashes, with the public, followed by a detailed description of their symptoms. Answers from other users are usually within minutes of the original post.1
The study found that 90% of posts received a reply in the course of 24 hours. In addition, 20% of the people asked the crowd for a second opinion after already being diagnosed by a medical professional for STDs.1
Experts say that the crowdsourcing trend might stem from a lack of money to pay for medical services or setting up a timely appointment with a doctor. However, this trend has stirred up mixed opinions with different doctors across the country.1
Dr. Amesh Adalja sees an opportunity in utilizing health care through social media. "This phenomenon should be seen as an opportunity for health care providers to engage with patients on social media to ensure accurate diagnosis and advice is being given," said Adalja, a senior scholar at the Johns Hopkins Center on Health Security in Baltimore who also reviewed the JAMA study. "Exploiting the ease of social media inquiry will likely become an increasingly important way to interact with patients."2
On the other hand, STD specialist Dr. Ina Park sees the downfall of crowdsourcing. “For those who already have a medical diagnosis and are still seeking a second opinion through crowdsourcing, I do think it’s potentially dangerous because you have no idea who’s giving you this advice and their expertise.”1
References
FDA Accepts Application for 5-in-1 Meningococcal Vaccine Candidate
April 17th 2024The 5-in-1 meningococcal ABCWY vaccine candidate has an assigned Prescription Drug User Fee Act action date of February 14, 2025.
Study Shows Diabetes, Pollution, Alcohol Intake Related to Onset of Cognitive Decline
April 3rd 2024A study about modifiable risk factors on a “weak spot” in the brain network found that diabetes, pollution, and alcohol were most likely to contribute to dementia disorders.
FDA Issues Letters to 6 Companies for Unapproved, Misbranded OTC Analgesic Products
March 28th 2024The agency warns consumers against using these products, which are marketed for topical use to relieve pain associated with cosmetic procedures.
Study: Lebrikizumab Demonstrates Improvements in Atopic Dermatitis for Patients of Color
March 20th 2024The efficacy data are consistent with other phase 3 studies, reinforcing lebrikizumab's potential as a first-line treatment across a range of skin tones.
Significant Events Throughout Life Increase Chances For Anxiety, Depression, and Cognitive Decline
March 13th 2024The findings also indicated that individuals who experienced significant adverse events in childhood were approximately 17% more likely to experience adverse events in adulthood.
Environmental Toxin BPA Affects Gut Microbial Communities in Children
March 6th 2024Children with normal weight had different community relationships compared to children with overweight or obesity.
FDA Accepts Application for 5-in-1 Meningococcal Vaccine Candidate
April 17th 2024The 5-in-1 meningococcal ABCWY vaccine candidate has an assigned Prescription Drug User Fee Act action date of February 14, 2025.
Study Shows Diabetes, Pollution, Alcohol Intake Related to Onset of Cognitive Decline
April 3rd 2024A study about modifiable risk factors on a “weak spot” in the brain network found that diabetes, pollution, and alcohol were most likely to contribute to dementia disorders.
FDA Issues Letters to 6 Companies for Unapproved, Misbranded OTC Analgesic Products
March 28th 2024The agency warns consumers against using these products, which are marketed for topical use to relieve pain associated with cosmetic procedures.
Study: Lebrikizumab Demonstrates Improvements in Atopic Dermatitis for Patients of Color
March 20th 2024The efficacy data are consistent with other phase 3 studies, reinforcing lebrikizumab's potential as a first-line treatment across a range of skin tones.
Significant Events Throughout Life Increase Chances For Anxiety, Depression, and Cognitive Decline
March 13th 2024The findings also indicated that individuals who experienced significant adverse events in childhood were approximately 17% more likely to experience adverse events in adulthood.
Environmental Toxin BPA Affects Gut Microbial Communities in Children
March 6th 2024Children with normal weight had different community relationships compared to children with overweight or obesity.